Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

March 1, 2019; Volume 60,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Nagengast, Wouter B.

    1. You have access
      Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
      Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit and Wouter B. Nagengast
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 418-423; DOI: https://doi.org/10.2967/jnumed.118.216556
  2. Nakajima, Reiko

    1. You have access
      18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
      Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L. Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D. Wolchok and Wolfgang A. Weber
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 335-341; DOI: https://doi.org/10.2967/jnumed.118.213652
  3. Nardo, Lorenzo

    1. You have access
      First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
      Ramsey D. Badawi, Hongcheng Shi, Pengcheng Hu, Shuguang Chen, Tianyi Xu, Patricia M. Price, Yu Ding, Benjamin A. Spencer, Lorenzo Nardo, Weiping Liu, Jun Bao, Terry Jones, Hongdi Li and Simon R. Cherry
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 299-303; DOI: https://doi.org/10.2967/jnumed.119.226498
  4. Nascimbene, Angelo

    1. Open Access
      Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
      K. Lance Gould, Nils P. Johnson, Amanda E. Roby, Tung Nguyen, Richard Kirkeeide, Mary Haynie, Dejian Lai, Hongjian Zhu, Monica B. Patel, Richard Smalling, Sal Arain, Prakash Balan, Tom Nguyen, Anthony Estrera, Stefano Sdringola, Mohammad Madjid, Angelo Nascimbene, Pranav Loyalka, Biswajit Kar, Igor Gregoric, Hazem Safi and David McPherson
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.118.211953
  5. Neels, Oliver

    1. Open Access
      Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
      Frederik L. Giesel, Karina Knorr, Fabian Spohn, Leon Will, Tobias Maurer, Paul Flechsig, Oliver Neels, Kilian Schiller, Horacio Amaral, Wolfgang A. Weber, Uwe Haberkorn, Markus Schwaiger, Clemens Kratochwil, Peter Choyke, Vasko Kramer, Klaus Kopka and Matthias Eiber
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 362-368; DOI: https://doi.org/10.2967/jnumed.118.212233
  6. Nguyen, Tom

    1. Open Access
      Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
      K. Lance Gould, Nils P. Johnson, Amanda E. Roby, Tung Nguyen, Richard Kirkeeide, Mary Haynie, Dejian Lai, Hongjian Zhu, Monica B. Patel, Richard Smalling, Sal Arain, Prakash Balan, Tom Nguyen, Anthony Estrera, Stefano Sdringola, Mohammad Madjid, Angelo Nascimbene, Pranav Loyalka, Biswajit Kar, Igor Gregoric, Hazem Safi and David McPherson
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.118.211953
  7. Nguyen, Tung

    1. Open Access
      Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease
      K. Lance Gould, Nils P. Johnson, Amanda E. Roby, Tung Nguyen, Richard Kirkeeide, Mary Haynie, Dejian Lai, Hongjian Zhu, Monica B. Patel, Richard Smalling, Sal Arain, Prakash Balan, Tom Nguyen, Anthony Estrera, Stefano Sdringola, Mohammad Madjid, Angelo Nascimbene, Pranav Loyalka, Biswajit Kar, Igor Gregoric, Hazem Safi and David McPherson
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 410-417; DOI: https://doi.org/10.2967/jnumed.118.211953
  8. Ni, Ai

    1. You have access
      18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
      Kimiteru Ito, Rebecca Teng, Heiko Schöder, John L. Humm, Ai Ni, Laure Michaud, Reiko Nakajima, Rikiya Yamashita, Jedd D. Wolchok and Wolfgang A. Weber
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 335-341; DOI: https://doi.org/10.2967/jnumed.118.213652
  9. Niepsch, Karin

    1. You have access
      Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients
      Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Karin Niepsch, Dirk Müller and Richard P. Baum
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 377-385; DOI: https://doi.org/10.2967/jnumed.118.215848
  10. Novakova, Zora

    1. You have access
      Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen
      Sangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, Donika Plyku, Zora Nováková, Mary Brummet, Bryan Wharram, Cyril Barinka, Robert Hobbs and Martin G. Pomper
      Journal of Nuclear Medicine March 1, 2019, 60 (3) 400-406; DOI: https://doi.org/10.2967/jnumed.118.214403
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (3)
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
  • 18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma
  • Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
  • First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire